Fah Sathirapongsasuti
Sr. Director, Data Science
Fah brings over a decade of biopharma experience, specializing in computational biology for target and drug discovery. At 23andMe’s Therapeutics Division, Fah was a founding scientist and pioneered the use of human genetics for drug target identification and prioritization. He has also led bioinformatics and data science teams as Director of Bioinformatics, Genetic Medicine at MedGenome and Director of Computational Biology at Alloy Therapeutics, focusing on data organization and tool development for next-generation therapeutics. Fah holds a PhD in Biostatistics from Harvard University and BS/MS degrees in Mathematical and Computational Science/Computer Science from Stanford University.
